Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about GSK plc

Recent news which mentions GSK plc

< Previous 1 2 Next >
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
Tags Breaking News: Business Social issues Health care industry
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Tags US: News Bristol/Myers Squibb Co Pharmaceuticals
From CNBC.com News
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Tags Biotech and Pharmaceuticals Business Health & Science
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Europe: Top News And Analysis Europe Politics Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags Johnson & Johnson Roche Holding AG GSK plc
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Health care industry Biotechnology Amgen Inc
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags Novo Nordisk A/S World News Europe News
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Biotech and Pharmaceuticals Markets Abbvie Inc
From CNBC.com News
Cramer's Lightning Round: 'You've got a winner in Cheesecake Factory'
Tags Mad Money AerCap Holdings NV Stock markets
From CNBC.com News
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
Tags Moderna Inc Novavax Inc Pfizer Inc
From CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Tags Companies Merck & Co Inc LILLY DRN
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Ironwood Pharmaceuticals Inc LILLY DRN Merck & Co Inc
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Madrigal Pharmaceuticals Inc Health care industry Amgen Inc
From CNBC.com News
Vaccine maker stocks fall on reports Trump plans to tap RFK Jr. to lead HHS
Tags Biotech and Pharmaceuticals Business Biontech SE
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Advanced Micro Devices Inc Stock markets Biogen Inc
From CNBC.com News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Tags US: News Sanofi SA Pharmaceuticals
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Healthy Returns Astellas Pharma Inc GSK plc
From CNBC.com News
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
Tags Pharmaceuticals US: News GSK plc
From CNBC.com News
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
Tags Pharmaceuticals US: News GSK plc
From CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Tags Labor economy Health care industry Biotechnology
From CNBC.com News
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Tags Merck & Co Inc Breaking news Health & Science
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
Tags Business Science Biotech and Pharmaceuticals
From CNBC.com News
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
Tags Pharmaceuticals Sanofi SA GSK plc
From CNBC.com News
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
Tags Science Biotech and Pharmaceuticals Moderna Inc
From CNBC.com News
Moderna says FDA delayed RSV vaccine approval to end of May
Tags Biotechnology Health care industry Business News
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Novo Nordisk A/S Teva Pharmaceutical Industries Ltd Biotech and Pharmaceuticals
From CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
Tags Respiratory syncytial virus Health care industry Biotechnology
From CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
Tags Health care industry AstraZeneca PLC GSK plc
From CNBC.com News
Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
Tags Biotechnology Health care industry Breaking news
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags Investment strategy L'Oreal SA Nestle SA
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.